Recap: Combination Therapy Shows Promise in Renal Cell Carcinoma
Experts present and discuss new findings from the CheckMate 9ER trial, evaluating nivolumab plus cabozantinib vs sunitinib in renal cell carcinoma.
Recap: Amivantamab as Second-line Option in Advanced NSCLC EGFR Exon 20 Mutation
A pair of experts explore the expanding treatment landscape in non–small cell lung cancer for patients with EGFR exon 20 insertion mutations.
Recap: Ribociclib Plus Letrozole in Low-Grade Serous Ovarian Cancer: ‘Provocative’ Early Signals from GOG 3026
"We’ve learned from our colleagues in breast cancer that there are opportunities to leverage this hormonal axis with combinations [including] a CDK4/6 [inhibitor]."
Recap: From RCC Diagnosis to Treatment, Toxicity Management, and Beyond
A panel of experts, a patient, and her caregiver discuss her renal cell carcinoma diagnosis, the prevalent treatment options, and optimal strategies for patient education.
Recap: Treatment Sequencing and Testing Strategies in HER2+ Colorectal Cancer
An expert panel reviews the management of toxicities, genetic testing, and other topics in colorectal cancer.
Recap: Personalized Therapy Options are on the Horizon for Multiple Myeloma
Ashley E. Rosko, MD, recaps a recent panel discussion on treatment options for multiple myeloma, and discusses the disease space more generally.
